Fremont, CA, United States of America

Padmanabha V Kattamuri

This inventor holds 2 USPTO granted patents. Top assignee: Arcus Biosciences, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Padmanabha V Kattamuri. Retrieved from https://idiyas.com/inventor/padmanabha-v-kattamuri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Padmanabha V Kattamuri

Introduction

Padmanabha V Kattamuri is an accomplished inventor based in Fremont, CA. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on Piperidylurea compounds. His research focuses on the development of compounds that can be utilized in the treatment of various diseases and disorders.

Latest Patents

Kattamuri holds a patent for Piperidylurea compounds and methods of use thereof. This patent describes compounds with a specific structure, as outlined in Formula II, and includes compositions containing these compounds. The patent also details methods for preparing the compounds and their applications in treating various medical conditions.

Career Highlights

Currently, Padmanabha V Kattamuri is associated with Arcus Biosciences, Inc., where he continues to advance his research in the pharmaceutical sector. His work has been instrumental in developing new therapeutic options for patients.

Collaborations

Kattamuri collaborates with notable colleagues, including Manmohan Reddy Leleti and Sandeep Dhanju, who contribute to his research efforts and innovations.

Conclusion

Padmanabha V Kattamuri's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…